3 Things You Need to Know
Standard of careIsn't working
You needIndividualized treatment
TimeIs of the essence
Patricia: Clinical Trial Patient
When Patricia’s glioblastoma came back after her first surgery, she and her husband both knew it was time to start looking at alternative treatment options. After extensive research, they discovered the hope they were looking for was actually right in their backyard at the Ivy Center in Phoenix.
Tumors We Treat
Common subtypes include astrocytoma, oligodendroglioma, glioblastoma, and gliosarcoma
Also known as ‘secondary’ brain tumors; originate from cancer in another part of the body
Primary brain tumors derived from the lining of the brain, known as the meninges
Arises from the ependymal cells that line the ventricles of the brain and the center of the spinal cord
Arises from small nests of cells near the pituitary stalk at the base of the skull, near the pituitary gland, third ventricle, and optic nerve
Occurs in the pineal region of the brain that may or may not involve the pineal gland
COMMUNITY OF CAREGIVERS
Ivy Brain Tumor Center Collaborates with GSK on New Phase 0 Clinical Trial to Evaluate Niraparib in Patients with Brain Cancer
The Ivy Center in collaboration with UCSF Department of Neurological Surgery is pleased to announce a new clinical trial of GSK’s niraparib (ZEJULA) – an FDA-approved drug to treat ovarian cancer – for patients with newly diagnosed glioblastoma and recurrent high-grade gliomas.
Robust Glioblastoma Clinical Trials Program Offers Brain Cancer Patients New Treatment Options
Ivy Brain Tumor Center and SonALAsense Announce Positive Initial Results of the First-in-Human Phase 0/1 Clinical Trial of Non-Invasive Sonodynamic Therapy for Recurrent Glioblastoma
The Ivy Brain Tumor Center’s clinical trial of sonodynamic therapy provides proof of concept for this new metabolically targeted, rapidly acting technology platform for brain tumors
It’s Personal: Dr. Kris Smith
As a neurosurgical oncologist at Barrow Neurological Institute, Dr. Kris Smith was determined to improve the outcome for brain tumor patients. But when his father was diagnosed with glioblastoma, the battle against brain cancer became all the more personal.
Brain tumor research HQ to be built on St. Joseph’s Phoenix campus
The Ivy Brain Tumor Center at Barrow Neurological Institute plans to build its 75,000-square-foot global headquarters on the campus of St. Joseph’s Hospital and Medical Center in Phoenix.